CrannMed
Galway, Ireland
CrannMed was founded in 2018 with the aim of bringing together world-leading clinical, material science and delivery system experts to deliver the benefits of resorbable embolisation to patients worldwide.Permanent microspheres have existed for more than 20 years, and are routinely used to treat liver cancer, uterine fibroids and benign prostate hyperplasia. Resorbable microspheres can be used to treat a range of new indications where it is desirable to restore blood flow to the targeted area after the desired therapeutic effect has been achieved.These resorbable microspheres have new applications in areas such as Knee Osteoarthritis (KOA) and Adhesive Capsulitis (Frozen Shoulder) and have the potential to replace permanent beads in existing applications. As well as a range of resorbable microspheres, CrannMed is developing a next generation microcatheter to help improve access for these unique applications plus a flow directed delivery system to protect collateral vessels and eliminate non-target embolisation.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- crannmed.com/
Categories
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of CrannMed?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now